These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 25112410)
41. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Menzies FM; Huebener J; Renna M; Bonin M; Riess O; Rubinsztein DC Brain; 2010 Jan; 133(Pt 1):93-104. PubMed ID: 20007218 [TBL] [Abstract][Full Text] [Related]
42. Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo. Watchon M; Luu L; Robinson KJ; Yuan KC; De Luca A; Suddull HJ; Tym MC; Guillemin GJ; Cole NJ; Nicholson GA; Chung RS; Lee A; Laird AS Mol Brain; 2021 Aug; 14(1):128. PubMed ID: 34416891 [TBL] [Abstract][Full Text] [Related]
43. Altered expression of carbonic anhydrase-related protein XI in neuronal cells expressing mutant ataxin-3. Hsieh M; Chang WH; Hsu CF; Nishimori I; Kuo CL; Minakuchi T Cerebellum; 2013 Jun; 12(3):338-49. PubMed ID: 23184527 [TBL] [Abstract][Full Text] [Related]
44. Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease. Simões AT; Gonçalves N; Nobre RJ; Duarte CB; Pereira de Almeida L Hum Mol Genet; 2014 Sep; 23(18):4932-44. PubMed ID: 24817574 [TBL] [Abstract][Full Text] [Related]
45. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance. Li X; Liu H; Fischhaber PL; Tang TS Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252 [TBL] [Abstract][Full Text] [Related]
46. RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease. Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Déglon N; de Almeida LP PLoS One; 2014; 9(8):e100086. PubMed ID: 25144231 [TBL] [Abstract][Full Text] [Related]
47. Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias. Colomer Gould VF NeuroRx; 2005 Jul; 2(3):480-3. PubMed ID: 16389311 [TBL] [Abstract][Full Text] [Related]
48. Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch. Furusho K; Yoshizawa T; Shoji S Neurobiol Dis; 2005 Oct; 20(1):170-8. PubMed ID: 16137577 [TBL] [Abstract][Full Text] [Related]
49. Caring for Machado-Joseph disease: current understanding and how to help patients. D'Abreu A; França MC; Paulson HL; Lopes-Cendes I Parkinsonism Relat Disord; 2010 Jan; 16(1):2-7. PubMed ID: 19811945 [TBL] [Abstract][Full Text] [Related]
50. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia. Nóbrega C; Mendonça L; Marcelo A; Lamazière A; Tomé S; Despres G; Matos CA; Mechmet F; Langui D; den Dunnen W; de Almeida LP; Cartier N; Alves S Acta Neuropathol; 2019 Nov; 138(5):837-858. PubMed ID: 31197505 [TBL] [Abstract][Full Text] [Related]
51. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease. Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979 [TBL] [Abstract][Full Text] [Related]
52. Far-infrared Radiation Improves Motor Dysfunction and Neuropathology in Spinocerebellar Ataxia Type 3 Mice. Liu SW; Chang JC; Chuang SF; Liu KH; Cheng WL; Chang HJ; Chang HS; Lin TT; Hsieh CL; Lin WY; Hsieh M; Kuo SJ; Liu CS Cerebellum; 2019 Feb; 18(1):22-32. PubMed ID: 29725949 [TBL] [Abstract][Full Text] [Related]
53. Expression of expanded polyglutamine protein induces behavioral changes in Drosophila (polyglutamine-induced changes in Drosophila). Kim YT; Shin SM; Lee WY; Kim GM; Jin DK Cell Mol Neurobiol; 2004 Feb; 24(1):109-22. PubMed ID: 15049515 [TBL] [Abstract][Full Text] [Related]
54. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049 [TBL] [Abstract][Full Text] [Related]
55. Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients? Emmel VE; Alonso I; Jardim LB; Saraiva-Pereira ML; Sequeiros J Clin Genet; 2011 Jan; 79(1):100-2. PubMed ID: 21143471 [No Abstract] [Full Text] [Related]
56. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437 [TBL] [Abstract][Full Text] [Related]
57. SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity. Zhou YF; Liao SS; Luo YY; Tang JG; Wang JL; Lei LF; Chi JW; Du J; Jiang H; Xia K; Tang BS; Shen L PLoS One; 2013; 8(1):e54214. PubMed ID: 23382880 [TBL] [Abstract][Full Text] [Related]
58. Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease. Simões AT; Gonçalves N; Koeppen A; Déglon N; Kügler S; Duarte CB; Pereira de Almeida L Brain; 2012 Aug; 135(Pt 8):2428-39. PubMed ID: 22843411 [TBL] [Abstract][Full Text] [Related]
59. Decreased protein synthesis of Hsp27 associated with cellular toxicity in a cell model of Machado-Joseph disease. Chang WH; Tien CL; Chen TJ; Nukina N; Hsieh M Neurosci Lett; 2009 Apr; 454(2):152-6. PubMed ID: 19429074 [TBL] [Abstract][Full Text] [Related]
60. Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3. Jung J; Xu K; Lessing D; Bonini NM Hum Mol Genet; 2009 Dec; 18(24):4843-52. PubMed ID: 19783548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]